Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts

Behavioural Pharmacology

Volumn 24, Issue 5-6, 2013, Pages 504-516

  Comer, Sandra D ^a   Metz, Verena E ^a   Cooper, Ziva D ^a   Kowalczyk, William J ^b   Jones, Jermaine D ^a   Sullivan, Maria A ^a   Manubay, Jeanne M ^a   Vosburg, Suzanne K ^a   Smith, Mary E ^a   Peyser, Deena ^a   Saccone, Phillip A ^c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

abuse liability; buprenorphine maintenance; human; morphine : oxycodone ratio; opioid dependence; physiological and subjective effects; self administration procedure

Indexed keywords

BUPRENORPHINE; CODEINE; HYDROCODONE; HYDROMORPHONE; MORPHINE; OXYCODONE; PETHIDINE; PLACEBO;

ADULT; ARTICLE; BREATHING RATE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG POTENCY; DRUG PREFERENCE; DRUG SELF ADMINISTRATION; END TIDAL CARBON DIOXIDE TENSION; FEMALE; HEART RATE; HUMAN; MALE; MONEY; OPIATE ADDICTION; PATIENT PREFERENCE; PRESCRIPTION; PUPIL; REINFORCEMENT; SYSTOLIC BLOOD PRESSURE; TASK PERFORMANCE; VISUAL ANALOG SCALE;

ADMINISTRATION, ORAL; ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; CHOICE BEHAVIOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHINE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; OXYCODONE; PAIN MEASUREMENT; PUPIL; QUESTIONNAIRES; REWARD; SELF ADMINISTRATION; TIME FACTORS; TOKEN ECONOMY; YOUNG ADULT;

EID: 84881544299     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e328363d1c4     Document Type: Article

References (21)

1. Backlund M, Lindgren L, Kajimoto Y, Rosenberg PH (1997). Comparison of epidural morphine and oxycodone for pain after abdominal surgery. J Clin Anesth 9:30-35
2. Barry DT, Savant JD, Beitel M, Cutter CJ, Moore BA, Schottenfeld RS, Fiellin DA (2012). Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxone. J Addict Med 6:274-279
3. Boström E, Hammarlund-Udenaes M, Simonsson US (2008). Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine. Anesthesiology 108:495-505
4. Cicero TJ, Ellis MS, Paradis A, Ortbal Z (2011). Role of key informants and direct patient interviews in epidemiological studies of substance abuse. Pharmacoepidemiol Drug Saf 20:308-312
5. Collins E, Kleber HD (2004). Opioids: Detoxification. In: Galanter M, Kleber HD, editors. Textbook of substance abuse treatment. 3rd ed Washington, DC: The American Psychiatric Publishing Incpp. 265-290
6. Comer SD, Collins ED, Fischman MW (1997). Choice between money and intranasal heroin in morphine-maintained humans. Behav Pharmacol 8:677-690
7. Comer SD, Collins ED, MacArthur RB, Fischman MW (1999). Comparison of intravenous and intranasal heroin self-Administration by morphine-maintained humans. Psychopharmacology (Berl) 143:327-328
8. Comer SD, Collins ED, Fischman MW (2001). Buprenorphine sublingual tablets: Effects on IV heroin self-Administration by humans. Psychopharmacology (Berl) 154:28-37
9. Comer SD, Collins ED (2002). Self-Administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers. J Pharmacol Exp Ther 303:695-703
10. Comer SD, Sullivan MA, Whittington RA, Vosburg SK, Kowalczyk WJ (2008). Abuse liability of prescription opioids compared to heroin in morphinemaintained heroin abusers. Neuropsychopharmacology 33:1179-1191
11. Fischer G, Gombas W, Eder H, Jagsch R, Peternell A, Stuehlinger G, et al. (1999). Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction 94:1337-1347
12. Heit HA, Gourlay DL (2008). Buprenorphine: New tricks with an old molecule for pain management. Clin J Pain 24:93-97
13. Kalso E (2007). How different is oxycodone from morphine? Pain 132:227-228
14. Manubay JM, Muchow C, Sullivan MA (2011). Prescription drug abuse: Epidemiology, regulatory issues, chronic pain management with narcotic analgesics. Prim Care 38:71-90, vi.
15. Mercadonte S, Caraceni A (2011). Conversion ratios for opioid switching in the treatment of cancer pain: A systematic review. Palliat Med 25:504-515
16. Schneider MF, Bailey JE, Cicero TJ, Dart RC, Inciardi JA, Parrino M, Munoz A (2009). Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiol Drug Saf 18:778-790
17. Silvasti M, Rosenberg P, Seppä lä T, Svartling N, Pitkänen M (1998). Comparison of analgesic efficacy of oxycodone and morphine in postoperative intravenous patient-controlled analgesia. Acta Anaesthesiol Scand 42:576-580
18. Stoops WW, Hatton KW, Lofwall MR, Nuzzo PA, Walsh SL (2010). Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: Abuse potential and relative potencies. Psychopharmacology (Berl) 212:193-203
19. Wang RIH, Wiesen RL, Lamid S, Roh BL (1974). Rating the presence and severity of opioid dependence. Clin Pharmacol Ther 16:653-658
20. Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, et al. (2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Arch Gen Psychiatry 68:1238-1246
21. Zacny JP, Lichtor SA (2008). Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-Drug-Abusing volunteers. Psychopharmacology (Berl) 196:105-116